All In MedTech

Device Trial Radar · NCT01065948

A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours

A Feasibility Study to Assess Critical Aspects of FAS Performance and Safety Over Several Hours

Last checked: Nov 19, 2026Latest source record: Feb 4, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

12

Actual

Start

Nov 2009

Primary completion

Jun 2012

Study completion Aug 2012

Sponsor

Lead sponsor
BioTex, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Endocrinoloogy Associates Houston
First posted
Feb 10, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical research study is to learn about a new minimally invasive glucose monitoring device called Fluorescence Affinity Sensor (FAS). In this study, the FAS will be used to determine its effectiveness for glucose monitoring. Researchers want to find out how the device performs at two different body sites (forearm and abdomen) over 4 hours. The safety and comfort level of the device will also be studied.

Conditions

  • Diabetes

Interventions

  • Subcutaneous glucose monitoring deviceDevice

    monitor interstitial glucose level every 5 min over 4 hours

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. examine accuracy of FAS response to glucose changes in subcutaneous tissue (compared to blood glucose concentrations measured with reference method)Time frame: 3 months
  2. monitor safety and performance of FAS response in two different body sites (abdomen, forearm)Time frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Practice of Eric Orzeck, MD

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.